Inhaled corticosteroids and the risks of diabetes onset and progression.
about
Stepping down asthma treatment: how and whenThe use of inhaled corticosteroids in pediatric asthma: updateEmerging Comorbidities in Adult Asthma: Risks, Clinical Associations, and MechanismsComorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and ManagementA re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary diseasePharmacological strategies to reduce exacerbation risk in COPD: a narrative reviewInhaled Corticosteroids for Chronic Obstructive Pulmonary Disease--The Shifting Treatment ParadigmChallenges in the pharmacological treatment of geriatric asthma.Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia.Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitusGlobal Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.Quantifying the real life risk profile of inhaled corticosteroids in COPD by record linkage analysisInhalational Steroids and Iatrogenic Cushing's SyndromeSystemic effects of inhaled corticosteroids: an overview.Effect of inhaled corticosteroids on glycemic status.Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.Does my patient have asthma?LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly.Patient-reported side effects, concerns and adherence to corticosteroid treatment for asthma, and comparison with physician estimates of side-effect prevalence: a UK-wide, cross-sectional study.Transient symptomatic hyperglycaemia secondary to inhaled fluticasone propionate in a young child.Exploring the impact of chronic obstructive pulmonary disease (COPD) on diabetes control in diabetes patients: a prospective observational study in general practice.Prevalence of diagnosed arthritis and arthritis-attributable activity limitation among adults with and without diagnosed diabetes: United States, 2008-2010.Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort Study.The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK.Contribution of the environment and comorbidities to chronic obstructive pulmonary disease phenotypes.Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practiceLong-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality.Outcome of Inhaler Withdrawal in Patients Receiving Triple Therapy for COPD.Effect of inhaled drugs on anxiety and depression in patients with chronic obstructive pulmonary disease: a prospective observational study.Randomized Trials Built on Sand: Examples from COPD, Hormone Therapy, and Cancer.Inhaled Corticosteroids Use Is Not Associated With an Increased Risk of Pregnancy-Induced Hypertension and Gestational Diabetes Mellitus: Two Nested Case-Control StudiesSecular changes in the age-specific prevalence of diabetes among U.S. adults: 1988-2010Comorbid diabetes and COPD: impact of corticosteroid use on diabetes complications.Inhaled corticosteroids in COPD and the risk of serious pneumonia.COPD and the metabolic syndrome: an intriguing association.Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD.How and when to use inhaled corticosteroids in chronic obstructive pulmonary disease?The pharmacological approach to the elderly COPD patient.
P2860
Q23916999-9E844356-543E-4533-A31F-81938478D107Q26739763-44CEDBB1-D6F0-4025-8B67-7BE00DBEEA08Q26747066-C480C03D-E380-48FC-B7E3-DDC0050572B1Q26799659-8901D50F-0639-4403-97AE-398B92EECAB1Q26801661-8C576850-EEF2-4BF2-A02D-6B80AA292E1CQ28070274-D0DCFC78-6BAA-43A7-947F-953FAC15F39BQ28087788-6F0B5662-756C-41F1-A0C4-110E33E42BF6Q30251770-A7158EFF-9328-4FD9-8DDE-C9174408F890Q33709357-BA5FFD88-4935-4123-9609-CC5A4B8F5199Q34065276-1CF646F5-88D0-4446-A931-293242787BFDQ34436462-767E3306-595F-4F43-8EAC-46FC4168FAB4Q34550471-788D5D24-6CC6-438A-AF29-F890525F6EE3Q34551086-7F1FFA83-369E-4286-A6E5-1C077767130AQ35056151-ADF17058-E78F-4EC3-9BA9-0CE58EFD004CQ35056155-7F03D070-9912-42B9-8941-6427172E68A9Q35056185-5B53B517-F84B-4F05-9B0B-B9564DF1341BQ35538249-C7DF1533-0054-41B9-BF75-B8BC7FEE7E05Q35703369-BCB46168-8BDE-4A5A-BF97-57FBCC804DA6Q35703517-24CB486F-E118-4578-9EF8-96547971CE91Q35765263-DFC521E9-462F-43A8-986E-EDC51A022572Q35834906-A58D25BD-A941-4001-A7A5-6CCAEF49F0F6Q35892139-C6496835-BF60-4862-85E6-77785FF4735CQ35939395-5EC1FC78-4070-4CE8-BAEB-D683B770212AQ36109139-A9E1F799-8F15-4EAD-B44A-60832FCD3650Q36141290-FD300088-C9BF-42B4-A9DD-047AE8D371A1Q36208427-58A5E071-A92B-42F9-87B0-7459CCDB2FC2Q36237935-6E3106FA-A61B-43AA-87CD-54E9C3E4769BQ36332206-21868EF5-E3A7-4367-A857-F5E8D0601BF2Q36421917-84DA0FB0-FEB7-45C2-90DB-CCA0DB654476Q36431478-60D6423B-8053-418D-A8CB-384541F2CE61Q36802786-B7BEC5D3-C6AE-46BD-924B-5378C9379B25Q36919212-E67BE00B-CF2A-481A-897E-11471E949B1CQ36988673-7CF4CDDB-39E9-4E88-9E2D-726FD4377DD6Q37106582-3EFE83B9-40E8-4F84-88F4-9A10F2FE57D0Q37193551-059682B7-511C-43D8-BBD1-8914F6D5265DQ37267655-C4460436-C186-4695-B3F4-4DFE660C3837Q37941499-8F17B89E-0736-42EE-908A-13EDF76DEC6FQ38058413-717612E0-D43D-4935-9AB5-3A20A1F03835Q38095559-62100332-26E1-4E9A-B89D-1FF7620FD322Q38098479-F20B8A4E-6A90-441A-9DCA-076C86CFFC07
P2860
Inhaled corticosteroids and the risks of diabetes onset and progression.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inhaled corticosteroids and the risks of diabetes onset and progression.
@ast
Inhaled corticosteroids and the risks of diabetes onset and progression.
@en
Inhaled corticosteroids and the risks of diabetes onset and progression.
@nl
type
label
Inhaled corticosteroids and the risks of diabetes onset and progression.
@ast
Inhaled corticosteroids and the risks of diabetes onset and progression.
@en
Inhaled corticosteroids and the risks of diabetes onset and progression.
@nl
prefLabel
Inhaled corticosteroids and the risks of diabetes onset and progression.
@ast
Inhaled corticosteroids and the risks of diabetes onset and progression.
@en
Inhaled corticosteroids and the risks of diabetes onset and progression.
@nl
P2093
P1476
Inhaled corticosteroids and the risks of diabetes onset and progression.
@en
P2093
Abbas Kezouh
Pierre Ernst
Samy Suissa
P304
P356
10.1016/J.AMJMED.2010.06.019
P407
P577
2010-10-01T00:00:00Z